Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.

摘要: This survival analysis was conducted at Ubon Ratchathani Cancer Center to determine the prognostic factors for of patients with stage IIIA, IIIB, and IV non-small-cell lung cancer (NSCLC) treated center between 1997-2001. The study sample included 210 cancer. Diagnosis staging were defined employing TNM system. majority smokers (66.7%), lived in Province (40.0%), male (77.6%), agriculturalists (74.8%). Seventy-seven percent died within five years, 19.5% lost follow-up 2.9% still alive 2003. estimated median time 6.3 months (95% CI 5.4-7.3); times stages 16.3, 7.0, 4.5 months, respectively. overall 1-, 2- 3-year rates NSCLC 28.9, 7.9, 3.3, differences various disease statistically significant (p < 0.0001), adjusted age sex. Treatment combination methods an early associated prolongation survival. For by treatment chemotherapy 7.0 radiotherapy 16.0 surgery others 16.3 plus 19.5 months. However, only versus significantly different = 0.0307). IIIB chemotherapy, radiotherapy, others, supportive 9.0, 14.7, 3.0 treatment, 0.0392, p 0.0433, respectively). IV, 5.0, 4.3, 6.5, 1.0 all 0.0020, 0.0001, 2-year 16.0, 4.1, 2.2%, results show that IIIA has longest time. They also appropriate is a factor improving patients.